Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jul 7;25(25):3183-3195.
doi: 10.3748/wjg.v25.i25.3183.

Infections with Helicobacter pylori and challenges encountered in Africa

Stella Smith  1 , Muinah Fowora  2 , Rinaldo Pellicano  3
Affiliations
Review

Infections with Helicobacter pylori and challenges encountered in Africa

Stella Smith et al. World J Gastroenterol. .

Abstract

Helicobacter pylori (H. pylori) is the causative agent of gastritis, peptic ulcer disease, mucosa associated lymphoid tissue lymphoma and gastric cancer (GC). While this bacterium infects 50% of the world's population, in Africa its prevalence reach as high as 80% as the infection is acquired during childhood. Risk factors for H. pylori acquisition have been reported to be mainly due to overcrowding, to have infected siblings or parent and to unsafe water sources. Despite this high H. pylori prevalence there still does not exist an African guideline, equivalent to the Maastricht V/Florence Consensus Report of the European Helicobacter and Microbiota Study Group for the management of this infection. In this continent, although there is a paucity of epidemiologic data, a contrast between the high prevalence of H. pylori infection and the low incidence of GC has been reported. This phenomenon is the so-called "African Enigma" and it has been hypothesized that it could be explained by environmental, dietary and genetic factors. A heterogeneity of data both on diagnosis and on therapy have been published. In this context, it is evident that in several African countries the increasing rate of bacterial resistance, mainly to metronidazole and clarithromycin, requires continental guidelines to recommend the appropriate management of H. pylori. The aim of this manuscript is to review current literature on H. pylori infection in Africa, in terms of prevalence, risk factors, impact on human health, treatment and challenges encountered so as to proffer possible solutions to reduce H. pylori transmission in this continent.

Keywords: Africa; African enigma; Diagnosis; Helicobacter pylori; Prevalence; Risk factors; Treatment.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: No potential conflict of interest and no financial support.

Figures

Figure 1
Figure 1
Laboratory-based antimicrobial resistance of Helicobacter pylori in Africa. AM: Amoxicillin; CLA: Clarithromycin; FLU: Fluoroquinolones; MET: Metronidazole; RIF: Rifampicin; TET: Tetracycline.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Peek RM, Jr, Crabtree JE. Helicobacter infection and gastric neoplasia. J Pathol. 2006;208:233–248. - PubMed
    1. Pizzorno JE, Murray MT, Joiner-Bey H. Peptic Ulcers. In: The clinicians handbook of Natural Medicine., editor. 3rd ed. St Lois, Missouri: Elsevier; 2016. pp. 779–786.
    1. Jonaitis L, Pellicano R, Kupcinskas L. Helicobacter pylori and nonmalignant upper gastrointestinal diseases. Helicobacter. 2018;23 Suppl 1:e12522. - PubMed
    1. IARC. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Vol. 61. Lyon: WHO press; 1994. pp. 1–241. - PMC - PubMed
    1. Rugge M, Fassan M, Graham DY. Epidemiology of gastric cancer. In: Strong V, editor. Gastric Cancer. Cham: Springer; 2015. pp. 23–32.

MeSH terms